Fig. 4

Nomogram to predict the overall survival of breast cancer patients undergoing neoadjuvant chemotherapy. A nomogram was generated based on ER, HER2, clinical T stage, clinical N stage, pCR and mSIS to predict OS (A). The 3-, 5-year and 8-year OS rates of the breast cancer patients predicted by the nomogram were highly consistent with the actual observed values (B, C, D). Comparison of the predictive ability between the nomogram, clinical TNM stage, NLR and ALB (E). Decision curve analyses (DCA) for the prognostic models of the nomogram, clinical TNM stage, NLR and ALB (F). The nomogram maps predict the probabilities onto the points on a scale from 0 to 100 and can be interpreted by adding the points together that correspond to the predicted probability. The total points were converted into the probabilities of survival for breast cancer patients after 3, 5 and 8 years